tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RANI Stock Latest News

Rani Therapeutics: Strategic Progress and Promising Pipeline Justify Buy Rating
RatingsRani Therapeutics: Strategic Progress and Promising Pipeline Justify Buy Rating
11h ago
RANI
Rani Therapeutics Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
Rani Therapeutics Faces Nasdaq Compliance Challenge
8d ago
8K
RANI
Rani Therapeutics Board Restructures After DeBuono’s Retirement
PremiumCompany Announcements
Rani Therapeutics Board Restructures After DeBuono’s Retirement
14d ago
8K
RANI
Rani Therapeutics management to meet virtually with Lake Street
PremiumThe Fly
Rani Therapeutics management to meet virtually with Lake Street
28d ago
RANI
Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials
PremiumRatings
Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials
1M ago
RANI
Rani Therapeutics: Promising Preclinical Data and Strong Financials Justify Buy Rating
PremiumRatingsRani Therapeutics: Promising Preclinical Data and Strong Financials Justify Buy Rating
1M ago
RANI
Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains
Premium
Company Announcements
Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains
1M ago
RANI
Rani Therapeutics’ RT-114: A Promising Contender in the $100 Billion Obesity Treatment Market
Premium
Ratings
Rani Therapeutics’ RT-114: A Promising Contender in the $100 Billion Obesity Treatment Market
1M ago
RANI
Rani Therapeutics Reports 2024 Financial Results and Updates
PremiumCompany Announcements
Rani Therapeutics Reports 2024 Financial Results and Updates
1M ago
RANI
Rani Therapeutics reports Q4 EPS (27c), consensus (23c)
PremiumThe Fly
Rani Therapeutics reports Q4 EPS (27c), consensus (23c)
1M ago
RANI
RANI Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RANI Upcoming Earnings Report: What to Expect?
2M ago
RANI
Rani announces pharmacokinetic, pharmacodynamic data from RT-114 trial
PremiumThe Fly
Rani announces pharmacokinetic, pharmacodynamic data from RT-114 trial
2M ago
RANI
Promising Potential of Rani Therapeutics: A Buy Rating on RT-114’s Market Prospects
PremiumRatingsPromising Potential of Rani Therapeutics: A Buy Rating on RT-114’s Market Prospects
2M ago
RANI
Promising Clinical Trial Results Propel Buy Rating for Rani Therapeutics Holdings
Premium
Ratings
Promising Clinical Trial Results Propel Buy Rating for Rani Therapeutics Holdings
2M ago
RANI
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ACET
ACHL
Mitchell Kapoor Upgrades Rani Therapeutics to ‘Buy’ on Promising Oral Semaglutide Data and Strategic Growth Initiatives
PremiumRatings
Mitchell Kapoor Upgrades Rani Therapeutics to ‘Buy’ on Promising Oral Semaglutide Data and Strategic Growth Initiatives
3M ago
RANI
Rani Therapeutics announces data from semaglutide via RaniPill capsule trial
PremiumThe Fly
Rani Therapeutics announces data from semaglutide via RaniPill capsule trial
3M ago
RANI
Rani Therapeutics Advances in Biotherapeutics Market
PremiumCompany Announcements
Rani Therapeutics Advances in Biotherapeutics Market
6M ago
RANI
Rani Therapeutics reports Q3 EPS (24c), consensus (29c)
PremiumThe Fly
Rani Therapeutics reports Q3 EPS (24c), consensus (29c)
6M ago
RANI
Rani Therapeutics Holdings options imply 12.6% move in share price post-earnings
PremiumThe FlyRani Therapeutics Holdings options imply 12.6% move in share price post-earnings
6M ago
RANI
Rani Therapeutics announces new preclinical PK data on GLP-1
Premium
The Fly
Rani Therapeutics announces new preclinical PK data on GLP-1
7M ago
RANI
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering
Premium
The Fly
Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering
7M ago
RANI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >